PSMA-Specific Theranostic Nanoplex for Combination of TRAIL Gene and 5-FC Prodrug Therapy of Prostate Cancer

Metastatic prostate cancer causes significant morbidity and mortality and there is a critical unmet need for effective treatments. We have developed a theranostic nanoplex platform for combined imaging and therapy of prostate cancer. Our prostate-specific membrane antigen (PSMA) targeted nanoplex is...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomaterials
Asıl Yazarlar: Chen, Zhihang, Penet, Marie-France, Krishnamachary, Balaji, Banerjee, Sangeeta R., Pomper, Martin G., Bhujwalla, Zaver M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706473/
https://ncbi.nlm.nih.gov/pubmed/26706476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.11.048
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller